19-35739294-C-A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_024660.4(IGFLR1):c.1054G>T(p.Val352Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000339 in 1,594,268 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024660.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGFLR1 | ENST00000246532.6 | c.1054G>T | p.Val352Phe | missense_variant | Exon 5 of 5 | 1 | NM_024660.4 | ENSP00000246532.1 | ||
ENSG00000267120 | ENST00000589807.1 | n.*1548G>T | non_coding_transcript_exon_variant | Exon 11 of 11 | 2 | ENSP00000472696.1 | ||||
ENSG00000267120 | ENST00000589807.1 | n.*1548G>T | 3_prime_UTR_variant | Exon 11 of 11 | 2 | ENSP00000472696.1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152228Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000103 AC: 24AN: 232486 AF XY: 0.000110 show subpopulations
GnomAD4 exome AF: 0.0000305 AC: 44AN: 1441922Hom.: 0 Cov.: 32 AF XY: 0.0000280 AC XY: 20AN XY: 714482 show subpopulations
GnomAD4 genome AF: 0.0000656 AC: 10AN: 152346Hom.: 0 Cov.: 33 AF XY: 0.0000805 AC XY: 6AN XY: 74508 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1054G>T (p.V352F) alteration is located in exon 5 (coding exon 4) of the IGFLR1 gene. This alteration results from a G to T substitution at nucleotide position 1054, causing the valine (V) at amino acid position 352 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at